Navigation Links
RxElite Registration Statement Declared Effective by Securities and Exchange Commission
Date:1/3/2008

MERIDIAN, Idaho, Jan. 3 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC Bulletin Board: RXEI), a developer, manufacturer, and marketer of specialty generic prescription drug products, announced today that a registration statement covering the resale of 53,747,555 shares by selling stockholders was declared effective by the Securities and Exchange Commission on January 2, 2008.

This notice is provided for informational purposes only, and does not represent a solicitation or offer to buy or sell any security. Any offer will be made my means of a current prospectus only. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sales of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contacts:

Corporate Information Investor Relations

Ph: (208) 288-5550 Charlie Forshee, 215-885-4981

Toll Free: (800) 414-1901 investorrelations@rxelite.com

Fax: (208) 288-1191 Segue Ventures LLC


'/>"/>
SOURCE RxElite, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. RxElite Announces 3rd Quarter Financials Conference Call
2. RxElite Files Registration Statement with Securities and Exchange Commission
3. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
4. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
5. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
6. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
7. Pearson Introduces Smart Technology for Collecting Patient Registration Information
8. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
9. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
10. Gentiva(R) Health Services Files Universal Shelf Registration Statement
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... D R Burton ... (OPEP) device, was featured in a study indicating superior performance against competitive products ... “Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: ... issue of world hunger, and shares the simple and achievable answer. “The Land of ... member of the Fairview Missionary Church in Angola, Indiana where he works with the ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Next week ... will be repealed by Congressional political games that circumvent health needs of over 30 ... Rally” capture the human anxieties and needs government public servants were suppose to prioritize. ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots , ... from around the world, announces the launch of its newly redesigned website. The ... to research breakthroughs and trending news, vital information on upcoming virtual events and ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is announcing their ... Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday ... recovery program. , “We know it’s easy to get carried away when ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Pfizer joins Astex, AstraZeneca, ... Consortium   Major research investment to ...   The Milner Therapeutics Institute today ... a partner to the Milner Therapeutics Consortium. Pfizer has ... transfer of materials between industry and academia and allocation ...
(Date:1/19/2017)... , January 19, 2017 The global  pacemaker market ... report by Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled ... growth of Pacemaker globally. In addition, technological enhancements in these devices are supporting ... ... Grand View Research Logo ...
(Date:1/19/2017)... LONDON , Jan. 18, 2017 The ... provides understanding and access to partnering deals and agreements ... - Trends in partnering deals - Top deals by ... stage of development, technology type The report provides ... entered into by the world,s leading healthcare companies. ...
Breaking Medicine Technology: